To determine the impact of ZEB1 loss in macrophages on tumor growth, we first employed a syngeneic subcutaneous (s.c.)model of CRC by injecting CMT-93 cells into LysMCtrl and LysMΔZeb1 mice. The gene discussed is ZEB1; the disease is neoplasm.